CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer.
- Resource Type
- Article
- Source
- International Journal of Gynecological Cancer; Aug2023, Vol. 33 Issue 8, p1247-1252, 6p
- Subject
- Language
- ISSN
- 1048891X